WeLeader Biomedical Co., Ltd.

NT$70.50As of Sun 8 Nov 2026, 12:00 UTC
TPEx:7713Healthcare
Country Taiwan
PE (Fwd) •••
TSR 3Y CAGR 6.68%
Div yield 5.82%
ROE 21.80%
Medical Devices
Beta (5Y) 0.11
PE TTM 13.95
TSR TTM 0.22%
Mkt cap NT$3.206B
ROIC 13.83%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$82
16.27%
(32.12%)
Hold 11|4|7|10|2
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.19
1.14
1.22
1.35
17.23%
3.17%
2.06%
18.18%
RevenueNT$M
158.6
156.2
154.7
160.9
(1.40%)
(1.49%)
(3.03%)
1.48%
Peers (US$96.84M)
Cap (US$)
PE
87.09M
15.27x
83.85M
—
76.16M
23.43x
Capital
TTM
5Y
10Y
Leveragex
3.896
(0.118)
(0.116)
EBIT/Intx
1.011
0.124
0.117
Own earn%
13.56
53.21
25.60
Sh yield%
38.33
31.95
28.32
Owners
Insiders/Inst%
2.46
80.71
Short interest%
1.56
SBC / revenue%
2.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
28–32
$1 testx
0.0
Incr. ROIC%
7